OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 335 citing articles:

10 Years of GWAS Discovery: Biology, Function, and Translation
Peter M. Visscher, Naomi R. Wray, Qian Zhang, et al.
The American Journal of Human Genetics (2017) Vol. 101, Iss. 1, pp. 5-22
Open Access | Times Cited: 3389

The IL-17 Family of Cytokines in Health and Disease
Mandy J. McGeachy, J. Daniel, Sarah L. Gaffen
Immunity (2019) Vol. 50, Iss. 4, pp. 892-906
Open Access | Times Cited: 1088

Psoriatic Arthritis
Christopher T. Ritchlin, Robert A. Colbert, Dafna D. Gladman
New England Journal of Medicine (2017) Vol. 376, Iss. 10, pp. 957-970
Closed Access | Times Cited: 1088

European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
Laure Gossec, Josef S Smolen, Sofía Ramiro, et al.
Annals of the Rheumatic Diseases (2015) Vol. 75, Iss. 3, pp. 499-510
Open Access | Times Cited: 885

IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases
Michele W.L. Teng, Edward P. Bowman, Joshua McElwee, et al.
Nature Medicine (2015) Vol. 21, Iss. 7, pp. 719-729
Closed Access | Times Cited: 779

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
Philip J. Mease, Iain B. McInnes, Bruce Kirkham, et al.
New England Journal of Medicine (2015) Vol. 373, Iss. 14, pp. 1329-1339
Open Access | Times Cited: 683

Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems
Kazuo Okamoto, Tomoki Nakashima, Masahiro Shinohara, et al.
Physiological Reviews (2017) Vol. 97, Iss. 4, pp. 1295-1349
Open Access | Times Cited: 439

2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis
Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, et al.
Arthritis Care & Research (2018) Vol. 71, Iss. 1, pp. 2-29
Open Access | Times Cited: 435

Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
Josef S Smolen, Daniel Aletaha
Nature Reviews Rheumatology (2015) Vol. 11, Iss. 5, pp. 276-289
Closed Access | Times Cited: 432

Interleukin 17 is a chief orchestrator of immunity
Marc Veldhoen
Nature Immunology (2017) Vol. 18, Iss. 6, pp. 612-621
Closed Access | Times Cited: 415

2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis
Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, et al.
Arthritis & Rheumatology (2018) Vol. 71, Iss. 1, pp. 5-32
Open Access | Times Cited: 395

Management of psoriasis as a systemic disease: what is the evidence?
Neil J. Korman
British Journal of Dermatology (2019) Vol. 182, Iss. 4, pp. 840-848
Open Access | Times Cited: 387

Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
Philip J. Mease, Mark C. Genovese, Maria Greenwald, et al.
New England Journal of Medicine (2014) Vol. 370, Iss. 24, pp. 2295-2306
Open Access | Times Cited: 376

IL-17 in Chronic Inflammation: From Discovery to Targeting
Audrey Beringer, Mélissa Noack, Pierre Miossec
Trends in Molecular Medicine (2016) Vol. 22, Iss. 3, pp. 230-241
Closed Access | Times Cited: 376

Interleukin-17 and innate immunity in infections and chronic inflammation
Natasa Isailovic, Kenji Daigo, Alberto Mantovani, et al.
Journal of Autoimmunity (2015) Vol. 60, pp. 1-11
Closed Access | Times Cited: 346

Diagnosis and classification of psoriasis
Smriti K. Raychaudhuri, Emanual Maverakis, S. P. Raychaudhuri
Autoimmunity Reviews (2014) Vol. 13, Iss. 4-5, pp. 490-495
Closed Access | Times Cited: 335

Psoriasis: Which therapy for which patient
Shivani B. Kaushik, Mark Lebwohl
Journal of the American Academy of Dermatology (2018) Vol. 80, Iss. 1, pp. 27-40
Closed Access | Times Cited: 318

Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases
Stefan Siebert, Alexander Tsoukas, Jamie Robertson, et al.
Pharmacological Reviews (2015) Vol. 67, Iss. 2, pp. 280-309
Open Access | Times Cited: 296

Interleukin‐17+CD8+ T Cells Are Enriched in the Joints of Patients With Psoriatic Arthritis and Correlate With Disease Activity and Joint Damage Progression
Bina Menon, Nicola Gullick, Gina Walter, et al.
Arthritis & Rheumatology (2014) Vol. 66, Iss. 5, pp. 1272-1281
Open Access | Times Cited: 258

Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 study
Philip J. Mease, Désirée van der Heijde, Robert Landewé, et al.
Annals of the Rheumatic Diseases (2018), pp. annrheumdis-212687
Open Access | Times Cited: 249

Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management
Ditte Marie Lindhardt Saunte, Ulrich Mrowietz, L. Puig, et al.
British Journal of Dermatology (2016) Vol. 177, Iss. 1, pp. 47-62
Closed Access | Times Cited: 238

Interleukin‐17A: a unique pathway in immune‐mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis
Bruce Kirkham, Arthur Kavanaugh, Kristian Reich
Immunology (2013) Vol. 141, Iss. 2, pp. 133-142
Open Access | Times Cited: 226

Ankylosing spondylitis: an autoimmune or autoinflammatory disease?
Daniele Mauro, Ranjeny Thomas, Giuliana Guggino, et al.
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 7, pp. 387-404
Closed Access | Times Cited: 225

Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies
Judy H. Cho, M Feldman
Nature Medicine (2015) Vol. 21, Iss. 7, pp. 730-738
Open Access | Times Cited: 220

Page 1 - Next Page

Scroll to top